Rapid Diagnostic Kits Market for Indian Ocean Region Countries (France, India, Australia, Indonesia, Singapore, Sri Lanka, Madagascar) by Product (Professional, OTC), Platform (Immunoassay, Molecular), Application (Infectious Diseases, Cardiac, Urinalysis, Cholesterol), End User (Hospital, Diagnostic Lab) - Forecast to 2029’, published by Meticulous Research®, the rapid diagnostics kits market for Indian Ocean region countries is expected to register a CAGR of 1.6% from 2022 to 2029 to reach $1.75 billion by 2029.
Download free sample report here: https://www.meticulousresearch.com/download-sample-report/cp_id=5418?utm_source=pr&utm_medium=social+&utm_campaign=product&utm_content=15-03-2024
Rapid Diagnostics Kits Market for Indian Ocean Region Countries: Future Outlook
The Rapid Diagnostics Kits Market for Indian Ocean Region Countries is segmented by Product (Professional Kits and OTC Kits), Platform (Immunoassays, Molecular Detection Tests, and Other Rapid Diagnostic Platforms), Application (Blood Glucose Testing, Cardiac Metabolism Testing, Infectious Diseases Testing, Pregnancy & Fertility Testing, Hematology Testing, Tumor/Cancer Markers Testing, Urinalysis, Cholesterol Testing, and Other Tests), End User (Hospitals & Clinics, Diagnostic Laboratories, Home Care/Self-testing, and Other End Users) and Geography (France, India, Australia, Singapore, Indonesia, Madagascar, Mauritius, Réunion, Comoros, Mayotte, and Seychelles). The study also evaluates industry competitors and analyzes their key growth strategies in the market.
Based on product, in 2022, the professional kits segment accounted for the larger share of the rapid diagnostic kits market in Indian Ocean region countries. The large market share of this segment is attributed to the higher preference for PoC testing, the high prevalence of chronic diseases, and technological advancements in rapid diagnostics, supporting the high adoption of professional kits. However, the OTC kits segment is expected to register the fastest growth over the forecast period. OTC kits are generally at-home testing kits used for fertility testing, blood glucose monitoring, cholesterol testing, and infectious and chronic disease testing. With home testing kits, patients can save time and money required for hospital/lab visits, as these tests can be performed at home, and results can be shared with physicians remotely. The growth of this segment can be attributed to the rising demand for at-home testing, growing awareness about self-testing among the general population, and the increasing prevalence of diseases that require rapid and effective testing.
Based on platform, in 2022, the immunoassays segment accounted for the largest share of the rapid diagnostic kits market in Indian Ocean region countries. However, the molecular detection segment is expected to register the fastest growth rate in the forecast period. PCR is crucial in clinical testing, including DNA fingerprinting, detecting bacteria or viruses, and diagnosing genetic disorders. The use of RT-PCR tests grew more than five-fold during the COVID-19 pandemic compared to the pre-pandemic period due to their higher reliability and accuracy. The increased popularity and awareness of RT-PCR diagnostic tests in developing countries such as India, Indonesia, and Singapore are mainly attributed to the high demand for RT-PCR diagnostic kits for coronavirus infection diagnosis. This increased popularity and awareness are expected to create significant growth opportunities for companies offering RT-PCR rapid diagnostic kits in these countries.
Click here for top trending blog: https://meticulousblog.org/top-10-companies-in-rapid-diagnostics-kits-market-for-indian-ocean-region-countries/?utm_source=pr&utm_medium=social+&utm_campaign=product&utm_content=15-03-2024
Based on application, in 2022, the infectious diseases testing segment accounted for the largest share of the rapid diagnostic kits market for Indian Ocean region countries. However, the tumor/cancer markers testing segment is expected to show the fastest growth rate in the forecast period. The burden of cancer is growing, exerting tremendous economic strain on countries. Nearly 70% of cancer deaths occur in low- and middle-income countries (source: WHO). The burden of cancer is large in India, Australia, Singapore, Indonesia, Madagascar, Mauritius, Réunion, Comoros, Mayotte, and Seychelles; for example, in 2020, India reported 1,324,413 new cancer cases and this number is projected to reach 1,692,968 by 2030(source: GLOBOCAN). Furthermore, France reported 467,965 new cancer cases and this number is projected to reach 530,863 by 2030 (source: GLOBOCAN). Early detection is very important in reducing mortality, improving the chances of survival, and saving on treatment costs. Various rapid diagnostic kits are used to detect cancer. It is estimated that the demand for rapid diagnostic kits that support cancer testing will grow significantly in the coming years.
Based on end user, in 2022, the hospitals & clinics segment accounted for the largest share of the rapid diagnostic kits market for Indian Ocean region countries. However, the home care/self-testing segment is expected to show the fastest growth rate in the forecast period. The home care/self-testing segment includes rapid diagnostic kits that can be directly used by the patient or general population at home with some specific healthcare needs. These kits are simple and easy to use and enable users to monitor themselves. The increasing prevalence of chronic diseases (requiring long-term care and frequent monitoring), growing awareness about home care, and the increasing geriatric population are driving the demand for rapid diagnostics in home settings.
Download request sample report here: https://www.meticulousresearch.com/request-sample-report/cp_id=5418?utm_source=pr&utm_medium=social+&utm_campaign=product&utm_content=15-03-2024
Based on Geography, France accounted for the largest share of the market in 2022. In France, the population aged 65 years and above is rising rapidly. According to the Organisation for Economic Co-operation and Development (OECD), the population aged 65 years and above in France is growing at a rate of 2.0% annually. According to the Council of the European Union, in 2019, 63% of the total population aged 65 years and above had at least one chronic disease. Thus, a high prevalence of chronic conditions among the elderly coupled with high access to healthcare services are supporting the largest share of this region.
Some of the key companies operating in the rapid diagnostic kits market for Indian Ocean region countries are Abbott Laboratories (U.S.), Becton, Dickinson and Company (U.S.), Bio-Rad Laboratories, Inc. (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), ACON Laboratories, Inc. (U.S.), Danaher Corporation (U.S.), Thermo Fisher Scientific Inc. (U.S.), bioMérieux S.A. (France), Alfa Scientific Designs, Inc. (U.S.), BTNX Inc. (Canada), Meridian Bioscience, Inc. (U.S.), and Trinity Biotech plc (Ireland).
Contact Us:
Meticulous Research®
Email- [email protected]
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
